JPM Q1 2026 Earnings Strong EPS Beat Despite Subdued Revenue Environment MIRA Q3 2025 Earnings Narrowed Loss Surpasses Expectations Amid No Revenue Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction SLMBP Q1 2026 Earnings Strong EPS Surprise of 356 Exceeds Expectations IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress IRIDEX Q1 2026 Earnings Narrowed Loss Surpasses Estimates Amid Operational Focus